153 related articles for article (PubMed ID: 23920443)
1. Economic analysis of vancomycin-resistant enterococci at a Canadian hospital: assessing attributable cost and length of stay.
Lloyd-Smith P; Younger J; Lloyd-Smith E; Green H; Leung V; Romney MG
J Hosp Infect; 2013 Sep; 85(1):54-9. PubMed ID: 23920443
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin-resistant Enterococcus colonization in the intensive care unit: clinical outcomes and attributable costs of hospitalization.
Jung E; Byun S; Lee H; Moon SY; Lee H
Am J Infect Control; 2014 Oct; 42(10):1062-6. PubMed ID: 25278394
[TBL] [Abstract][Full Text] [Related]
3. Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting.
Montecalvo MA; Jarvis WR; Uman J; Shay DK; Petrullo C; Horowitz HW; Wormser GP
Infect Control Hosp Epidemiol; 2001 Jul; 22(7):437-42. PubMed ID: 11583213
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin-resistant enterococci colonization does not increase mortality in end-stage kidney failure: a case-control study.
Garner SE; Polkinghorne KR; Kotsanas D; Kerr PG; Korman TM; Stuart RL
J Hosp Infect; 2013 Dec; 85(4):289-96. PubMed ID: 24161798
[TBL] [Abstract][Full Text] [Related]
5. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization.
Cheah AL; Spelman T; Liew D; Peel T; Howden BP; Spelman D; Grayson ML; Nation RL; Kong DC
Clin Microbiol Infect; 2013 Apr; 19(4):E181-9. PubMed ID: 23398607
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomes.
Pelz RK; Lipsett PA; Swoboda SM; Diener-West M; Powe NR; Brower RG; Perl TM; Hammond JM; Hendrix CW
Intensive Care Med; 2002 Jun; 28(6):692-7. PubMed ID: 12107672
[TBL] [Abstract][Full Text] [Related]
7. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.
Mauldin PD; Salgado CD; Durkalski VL; Bosso JA
Ann Pharmacother; 2008 Mar; 42(3):317-26. PubMed ID: 18285560
[TBL] [Abstract][Full Text] [Related]
8. The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients.
Salgado CD
Am J Infect Control; 2008 Dec; 36(10):S175.e5-8. PubMed ID: 19084155
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of vancomycin-resistant enterococcus colonization at Gaziantep Children's Hospital, Turkey].
Yiş R; Aslan S; Cıtak C; Değirmenci S
Mikrobiyol Bul; 2011 Oct; 45(4):646-54. PubMed ID: 22090295
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus.
Muto CA; Giannetta ET; Durbin LJ; Simonton BM; Farr BM
Infect Control Hosp Epidemiol; 2002 Aug; 23(8):429-35. PubMed ID: 12186207
[TBL] [Abstract][Full Text] [Related]
11. Attributable costs of enterococcal bloodstream infections in a nonsurgical hospital cohort.
Butler AM; Olsen MA; Merz LR; Guth RM; Woeltje KF; Camins BC; Fraser VJ
Infect Control Hosp Epidemiol; 2010 Jan; 31(1):28-35. PubMed ID: 19951200
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin-resistant enterococci in Canada: results from the Canadian nosocomial infection surveillance program, 1999-2005.
Ofner-Agostini M; Johnston BL; Simor AE; Embil J; Matlow A; Mulvey M; Ormiston D; Conly J;
Infect Control Hosp Epidemiol; 2008 Mar; 29(3):271-4. PubMed ID: 18241031
[TBL] [Abstract][Full Text] [Related]
13. Significant reduction in vancomycin-resistant enterococcus colonization and bacteraemia after introduction of a bleach-based cleaning-disinfection programme.
Grabsch EA; Mahony AA; Cameron DR; Martin RD; Heland M; Davey P; Petty M; Xie S; Grayson ML
J Hosp Infect; 2012 Dec; 82(4):234-42. PubMed ID: 23103245
[TBL] [Abstract][Full Text] [Related]
14. Consequences of vancomycin-resistant Enterococcus in liver transplant recipients: a matched control study.
Gearhart M; Martin J; Rudich S; Thomas M; Wetzel D; Solomkin J; Hanaway MJ; Aranda-Michel J; Weber F; Trumball L; Bass M; Zavala E; Steve Woodle E; Buell JF
Clin Transplant; 2005 Dec; 19(6):711-6. PubMed ID: 16313314
[TBL] [Abstract][Full Text] [Related]
15. [Vancomycin-resistant enterococci: prevalence and factors associated with intestinal colonization in oncology patients from Hospital de Niños de Córdoba].
Reale AL; Depetri ML; Culasso C; Paviolo M; Cheguirián ML; Enrico MC; Ledesma EM; Vidal C; Glatstein E; Bertoni L
Rev Argent Microbiol; 2009; 41(2):92-6. PubMed ID: 19623898
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin-resistant Enterococcus colonization before admission to the intensive care unit: a clinico-epidemiologic analysis.
Song JY; Cheong HJ; Jo YM; Choi WS; Noh JY; Heo JY; Kim WJ
Am J Infect Control; 2009 Nov; 37(9):734-40. PubMed ID: 19188004
[TBL] [Abstract][Full Text] [Related]
17. Incidence and risk factors of vancomycin-resistant enterococcus colonization in burn unit patients.
Altoparlak U; Koca O; Ozkurt Z; Akcay MN
Burns; 2011 Feb; 37(1):49-53. PubMed ID: 20926196
[TBL] [Abstract][Full Text] [Related]
18. Controlling for endogeneity in attributable costs of vancomycin-resistant enterococci from a Canadian hospital.
Lloyd-Smith P
Am J Infect Control; 2017 Dec; 45(12):e161-e164. PubMed ID: 29056328
[TBL] [Abstract][Full Text] [Related]
19. Surveillance and endemic vancomycin-resistant enterococci: some success in control is possible.
Morris-Downes M; Smyth EG; Moore J; Thomas T; Fitzpatrick F; Walsh J; Caffrey V; Morris A; Foley S; Humphreys H
J Hosp Infect; 2010 Jul; 75(3):228-33. PubMed ID: 20363048
[TBL] [Abstract][Full Text] [Related]
20. [Risk factors and clinical outcomes for vancomycin-resistant enterococcus colonization on intensive care unit admission].
Byun SJ; Kang J
J Korean Acad Nurs; 2013 Apr; 43(2):287-95. PubMed ID: 23703606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
